Chronic cholecystitis at patients with the various trophological status: mechanisms and feature of clinical course
Abstract
Aim of investigation. To analyze clinical, biochemical features of various forms of pathology of a gallbladder in view of features of food behavior and factors of its regulation at patients with the various trophological status.
Material and methods. Overall 167 patients with gallbladder diseases and various trophological status were included in original study. Food behavior analysis was carried out, clinical features, anthopometry were determined, bile lipid spectrum, serum content of leptin and insulin were studied by enzyme-linked immunoassay.
Results. Investigation of gallbladder diseases has objectively demonstrated, that trophological status affects development and course of chronic cholecystitis, but is not the only determining factor.
Conclusions. Development and course of gallbladder diseases are defined by trophological status based on disorders of food behavior, change of production of leptin, insulin.
About the Authors
Ye. V. Anisimova
State educational government-financed institution of higher professional education Razumovsky Saratov State Medical University, Ministry of Healthcare Russia
Russian Federation
Russian Federation
Anisimova Yekaterina V — post-graduate student of chair of internal diseases, pediatric and stomatologic faculties
410012, Russia, Saratov, B. Kazach'ya str., 112
I. V. Kozlova
State educational government-financed institution of higher professional education Razumovsky Saratov State Medical University, Ministry of Healthcare Russia
Russian Federation
Russian Federation
Kozlova Irina V — MD, PhD, professor, head of the chair of internal diseases, pediatric and stomatologic faculties
S. V. Volkov
State educational government-financed institution of higher professional education Razumovsky Saratov State Medical University, Ministry of Healthcare Russia
Russian Federation
Russian Federation
Volkov Stanislav V — MD, assistant-professor, chair of internal diseases, pediatric and stomatologic faculties
References
1. Glasgow RE, Mulvihill SJ. Treatment of gallstone disease. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease. 9th ed. Philadelphia, Pa: Saunders Elsevier 2010:66.
2. Циммерман ЯС. Гастроэнтерология: Руководство. М.: ГЭОТАР-Медиа 2012:20-5.
3. Лазебник ЛБ., Ильченко АА. Желчнокаменная болезнь. Пути решения проблемы. Тер арх 2005; 2:5-10.
4. Ильченко АА, Делюкина ОВ, Вихрова ТВ. Патогенетические и клинические аспекты предкаменной стадии желчнокаменной болезни. Мед вестн 2006; 3:14-5.
5. Никитин ЮП, Григорьева ИН. Женские половые гормоны и некоторые другие факторы в патогенезе желчнокаменной болезни. Тер арх 2005; 2:89-92.
6. Erlinger S. Gallstones in obesity and weight loss. Eur J Gastroenterol Hepatol 2000; 12 (12):1347-52.
7. Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D, et al. Metabolic syndrome as a risk factor for gallstone disease // World J Gastroenterol 2005; 11 (11):1653-7.
8. Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep 2005;7(2):132-40.
9. Мараховский ЮХ. Желчнокаменная болезнь: современное состояние проблемы. Рос журн гастроэнтерол гепатол колопроктол 2003; 13 (1):81-91.
10. Звенигородская ЛА. Клинико-функциональные и морфологические изменения в печени у больных с метаболическим синдромом. Consilium Medicum 2007; 2:3-10.
11. Медведева ИВ, Фролова ОИ, Дороднева ЕФ, Янин ЕЛ. Желчнокаменная болезнь и ожирение. Особенности клиники, патогенеза и лечения. Монография. Тюмень: «Академия», 2003:147.
12. Мараховский ЮХ, Мараховский КЮ. Гастроэнтерологические аспекты обмена холестерина: гепатоцитарные и каналикулярные компартменты обмена холестерина и их клинико-патофизиологическое значение. Рос журн гастроэнтерол гепатол колопроктол 2006; 16 (6):41-55.
13. Вовк ЕИ. Желчнокаменная болезнь в XXI веке: что нового? Леч врач 2011; 2:58-65.
14. Манцорос ХС. Современные представления о роли лептина в развитии ожирения и связанных с ним заболеваний человека. Междунар журн мед практики 2000; 9:57-67.
15. Fruhbeek G, Salvador J. Relation between leptin and regulatic of glucose metabolism. Diabetologia 2000 43(1):3-12.
16. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med 2008; 11-12:741-51.
17. Мансуров ХХ, Мироджов ГК, Мансурова ФХ, и др. Инсулинорезистентность у больных метаболическим синдромом и желчнокаменной болезнью. Клин мед 2005; 83 (7):48-51.
Review
For citations:
Anisimova Ye.V., Kozlova I.V., Volkov S.V. Chronic cholecystitis at patients with the various trophological status: mechanisms and feature of clinical course. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2014;24(3):36-41. (In Russ.)
Views:
120
Email this article 
